Cameco is one of the world's largest uranium producers, and the question for the next twelve months is whether the structural tailwinds from the global nuclear renaissance can offset the normal quarterly variability in deliveries and the Westinghouse Dukovany construction-project timing that is now annualizing. The Q2 2026 print was deliberately described by management as one of "normal quarterly variability" rather than an inflection, and the cleanest signal is that the H1 2026 adjusted EBITDA of $899 million, the $1.1 billion of cash and cash equivalents, the $1.0 billion of total debt, and the $1.0 billion undrawn revolving credit facility place Cameco at the strongest balance sheet position the company has held in years, even as the Q2 2026 net earnings of $25 million and adjusted net earnings of $77 million came in below the prior-year quarter because of the lapping of the Westinghouse Dukovany project revenue. The strategic tension is the long-term uranium price tailwind and the Cigar Lake ownership increase and the AP1000 reactor policy support against the near-term sales volume contraction from the company's contracting discipline, and the forward question is whether the Westinghouse confidential S-1 filing in late July 2026 - a prelude to a potential IPO that would create a public market value for Cameco's stake - is the next material catalyst.